Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert V Bryant

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Best Practice & Research. Clinical Gastroenterology|July 23, 2019
Interfering with leukocyte trafficking in Crohn's diseaseSujata Biswas, Robert V Bryant, Simon Travis
Journal of Gastroenterology and Hepatology|October 16, 2020
Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemicThomas M Goodsall, Sangwoo Han, Robert V Bryant
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 14, 2020
Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's diseaseAlice Day, Jessica Wood, Sarah Melton, et al.
Australian Prescriber|April 30, 2020
Faecal microbiota transplantation: indications, evidence and safetyWei Ting Soo, Robert V Bryant, Samuel P Costello
Scandinavian Journal of Gastroenterology|December 20, 2014
Conventional drug therapy for inflammatory bowel diseaseRobert V Bryant, Oliver Brain, Simon P L Travis
Nature Reviews. Gastroenterology & Hepatology|September 2, 2016
Current best practice for disease activity assessment in IBDAlissa J Walsh, Robert V Bryant, Simon P L Travis
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|August 14, 2019
Uncovering the cause of ulcerative colitisIan C Roberts-Thomson, Robert V Bryant, Samuel P Costello
Journal of Crohn'S & Colitis|October 8, 2013
Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?Robert V Bryant, Vipul Jairath, Nicola Curry, et al.
Internal Medicine Journal|December 1, 2025
Balancing costs and care: evaluating the need for novel therapies for immune-mediated inflammatory diseases in AustraliaDamjana Bogatic, Miles P Sparrow, Ray K Boyapati, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2022
Systematic review: microbial manipulation as therapy for primary sclerosing cholangitisDamjana Bogatic, Robert V Bryant, Kate D Lynch, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Best Practice & Research. Clinical Gastroenterology|July 23, 2019
Interfering with leukocyte trafficking in Crohn's diseaseSujata Biswas, Robert V Bryant, Simon Travis
Journal of Gastroenterology and Hepatology|October 16, 2020
Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemicThomas M Goodsall, Sangwoo Han, Robert V Bryant
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 14, 2020
Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's diseaseAlice Day, Jessica Wood, Sarah Melton, et al.
Australian Prescriber|April 30, 2020
Faecal microbiota transplantation: indications, evidence and safetyWei Ting Soo, Robert V Bryant, Samuel P Costello
Scandinavian Journal of Gastroenterology|December 20, 2014
Conventional drug therapy for inflammatory bowel diseaseRobert V Bryant, Oliver Brain, Simon P L Travis
Nature Reviews. Gastroenterology & Hepatology|September 2, 2016
Current best practice for disease activity assessment in IBDAlissa J Walsh, Robert V Bryant, Simon P L Travis
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|August 14, 2019
Uncovering the cause of ulcerative colitisIan C Roberts-Thomson, Robert V Bryant, Samuel P Costello
Journal of Crohn'S & Colitis|October 8, 2013
Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?Robert V Bryant, Vipul Jairath, Nicola Curry, et al.
Internal Medicine Journal|December 1, 2025
Balancing costs and care: evaluating the need for novel therapies for immune-mediated inflammatory diseases in AustraliaDamjana Bogatic, Miles P Sparrow, Ray K Boyapati, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2022
Systematic review: microbial manipulation as therapy for primary sclerosing cholangitisDamjana Bogatic, Robert V Bryant, Kate D Lynch, et al.
Pageof 9